Related Experiment Video

Updated: Jun 5, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Heterogeneity in multiple sclerosis: scratching the surface of a complex disease

Giulio Disanto1, Antonio J Berlanga, Adam E Handel

  • 1Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Headington, Oxford, OX3 7BN, UK.

Autoimmune Diseases
|January 4, 2011
PubMed

Insights

Multiple Sclerosis (MS) exhibits significant patient heterogeneity, impacting disease course and treatment. Understanding these MS subtypes is crucial for personalized medicine and predicting patient outcomes.

Area of Science:

  • Neuroimmunology
  • Neurology
  • Genetics

Background:

  • Multiple Sclerosis (MS) is a leading demyelinating disease of the central nervous system.
  • Despite extensive research, a single etiological pathway, diagnostic method, or universal treatment for MS remains elusive.
  • Patient heterogeneity is a significant barrier to understanding MS pathogenesis and developing effective therapies.

Purpose of the Study:

  • To investigate the heterogeneity within the Multiple Sclerosis (MS) population.
  • To explore the influence of genetic and environmental factors on MS variability.
  • To highlight the importance of recognizing MS subtypes for future research and clinical applications.

Main Methods:

  • Review of existing etiological and pathogenetic studies in Multiple Sclerosis.
  • Analysis of clinical variability, genetic associations (including HLA-DRB1*15:01), and pathological/immunological findings.
  • Synthesis of data to propose a framework for understanding MS heterogeneity.

Main Results:

  • MS presents with highly variable clinical courses, subcategories, and variants.
  • Genetic factors, such as the HLA-DRB1*15:01 allele, show population-specific variations.
  • Pathological and immunological evidence suggests distinct active pathways in different MS patients.

Conclusions:

  • Multiple Sclerosis subtypes exist within the broader disease spectrum.
  • Spatiotemporal interactions of genetic and environmental factors likely drive differential MS progression.
  • Recognizing MS subtypes is essential for advancing outcome prediction and personalized medicine in MS research.

More Related Videos

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis05:44

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

Published on: October 13, 2023

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...